WNDM Medical Inc.

With our number one goal of improving patient outcomes, WNDM Medical Inc., develops, markets and distributes biotechnology products to physicians, hospitals and clinics. We have a strong history of developing long-term, strategic partnerships with a focus on products that fuse nature with science. With a steady focus on innovation and growth, we hold licenses and patents to technologies and processes that ultimately make a positive impact on clinical outcomes for patients.

Our primary products are in the $11 billion U.S. consumable medical device market and in the $1.5 billion biomaterials market. We project rapid revenue growth based on increasing sales from our FDA-cleared CellerateRX® Surgical Activated Collagen® Adjuvant, as well as anticipated revenues from our FDA-cleared HemaQuell® Resorbable Bone Hemostat.